Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7103
-0.0028 (-0.39%)
Nov 19, 2025, 1:21 PM EST - Market open
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $29 million as of November 19, 2025. Its market cap has decreased by -48.62% in one year.
Market Cap
29.00M
Enterprise Value
-33.59M
1-Year Change
-48.62%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $29.00M, a decrease of -94.99%. That is a compound annual growth rate of -48.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 29.12M | -40.09% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | 579.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |